Does sickle cell disease increase risk of adverse outcomes following total hip and knee arthroplasty? A nationwide database study | oneSCDvoice
  • Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials
scientific articles

Does sickle cell disease increase risk of adverse outcomes following total hip and knee arthroplasty? A nationwide database study

key information

source: The Journal of Arthroplasty

year: 2015

authors: Perfetti DC, Boylan MR, Naziri Q, Khanuja HS, Urban WP

summary/abstract:

Sickle cell disease (SCD) is associated with impaired vascular function and progressive vaso-occlusive injury to bones. We used the Nationwide Inpatient Sample to identify all THA and TKA admissions between 1998 and 2010. After controlling for patient age, gender, insurance, race, and comorbidities, the risk of complication among admissions with SCD was 152% higher (P<0.001) for THA and 137% higher (P=0.001) for TKA. Patients with SCD had a length of stay that was 42% longer (P<0.001) for THA and 20% longer for TKA (P<0.001), and hospital charges that were 19% higher (P<0.001) for THA and 16% higher (P=0.001) for TKA. Orthopedic surgeons should counsel potential THA and TKA candidates with SCD of these risks prior to admission.

organisation: SUNY Downstate Medical Center, Brooklyn; The Johns Hopkins University, Baltimore

DOI: 10.1016/j.arth.2014.10.035

read more full text source